ARCHIVES

Phase III Avastin Trial Fails Primary Endpoints

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

October 31, 2014

Vaccine Prevented Cervical Pre-Cancers, Non-Invasive Cancers In Phase III Trial

October 28, 2005

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979

FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat

January 31, 2014

In Brief: Candlelight Vigil At Lincoln Memorial Planned For Night Before Cancer March

March 6, 1998

ACS Prostate Cancer Recommendations Move Forward

August 7, 1992